Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma. (Record no. 27515594)

MARC details
000 -LEADER
fixed length control field 01424 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517172121.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201905s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1398-9995
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/all.13302
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Casale, T B
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190503
245 00 - TITLE STATEMENT
Title Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Allergy
Date of publication, distribution, etc. 02 2018
300 ## - PHYSICAL DESCRIPTION
Extent 490-497 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Asthmatic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Asthma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biological Products
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Omalizumab
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Patient Selection
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Severity of Illness Index
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chipps, B E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rosén, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Trzaskoma, B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Haselkorn, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Omachi, T A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Greenberg, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hanania, N A
773 0# - HOST ITEM ENTRY
Title Allergy
Related parts vol. 73
-- no. 2
-- p. 490-497
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/all.13302">https://doi.org/10.1111/all.13302</a>
Public note Available from publisher's website

No items available.